Dr. Katherine Warren, MD

• Pediatric Hematology & Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• National Cancer Institute

  Fellowship Hospital

• Children's National Medical Center

  Residency Hospital

• Tufts University School Of Medicine

  Medical School, 1990

• Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors, 2021-06-08

• Quantification of Temozolomide in Nonhuman Primate Fluids by Isocratic Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry to Study Brain Tissue Penetration Following Intranasal or Intravenous Delivery, 2016-02-04

• Single and multi-voxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma, 2012-03-23

• Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma, 2011-05-13

• Cerebrospinal fluid penetration of the colony-stimulating factor-1 receptor (CSF-1R) inhibitor, pexidartinib, 2020-04-18

• Phase I trial of convection-enhanced delivery of IL13-Pseudomonastoxin in children with diffuse intrinsic pontine glioma, 2018-12-07

• Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primates, 2015-12-10

• Gliomatosis cerebri: a consensus summary report from the Second International Gliomatosis cerebri Group Meeting, June 22-23, 2017, Bethesda, USA, 2018-07-11

• The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease, 2017-01-16

• Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors, 2022-04-28

• Spontaneously regressing brain lesions in Smith-Lemli-Opitz syndrome, 2017-12-11

• The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants, 2016-11-17

• Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient derived liquid biopsy, 2018-10-15

• Characterizing the pharmacokinetics of panobinostat in a non-human primate model for the treatment of diffuse intrinsic pontine glioma, 2020-01-01

• Gliomatosis Cerebri: Current Understanding and Controversies, 2017-08-07

• Pharmacokinetics of temozolomide administered in combination with O6-benzylguanine in children and adolescents with refractory solid tumors, 2009-05-09

• Unclear standard of care for pediatric high grade glioma patients, 2013-03-08

• Time-to-event Bayesian Optimal Interval Design to Accelerate Phase I Trials, 2018-05-16

• Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors, 2015-01-03

• A Phase I Trial of Lenalidomide and Radiotherapy in Children with Diffuse Intrinsic Pontine Gliomas or High-Grade Gliomas, 2020-10-11

• Diffusion Tensor Histogram Analysis of Pediatric Diffuse Intrinsic Pontine Glioma, 2014-06-11

• Phase 1 Study of Pomalidomide in Children with Recurrent, Refractory and Progressive Central Nervous System Tumors: A Pediatric Brain Tumor Consortium Trial, 2020-10-07

• A Phase II Study of Pegylated Interferon Alfa-2b (PEG-Intron®) in Children with Diffuse Intrinsic Pontine Glioma (DIPG), 2011-11-15

• Magnetic resonance imaging properties of convective delivery in diffuse intrinsic pontine gliomas, 2014-01-10

• Secondary Supratentorial Primitive Neuroectodermal Tumor Following Treatment of Childhood Osteosarcoma, 2009-06-17

• Functionally-defined Therapeutic Targets in Diffuse Intrinsic Pontine Glioma A Report of the Children's Oncology Group DIPG Preclinical Consortium, 2015-05-04

• Trends in pediatric central nervous system tumor incidence in the United States, 1998-2013, 2018-11-21

• Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model, 2017-03-13

• Challenges With Defining Response to Antitumor Agents in Pediatric Neuro-Oncology: A Report From the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group, 2013-04-26

• The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates, 2011-06-26

• The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma, 2017-04-25

• Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells, 2018-04-30

• Measurements of the pons as a biomarker of progression for pediatric DIPG, 2013-10-10

• Novel therapeutic delivery approaches in development for pediatric gliomas, 2013-09-01

• Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening, 2019-11-20

• The role of early post radiation MRI scans in children with diffuse intrinsic pontine glioma (DIPG), 2012-01-25

• Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma, 2016-04-06

• What Do Parents Want To Know When Considering Autopsy For Their Child With Cancer?, 2014-01-28

• Molecular imaging of pediatric brain tumors: comparison of tumor metabolism using18F-FDG-PET and MRSI, 2012-07-04